AA
DXCM icon

Alta Advisers’s DexCom DXCM Stock Holding History

Alta Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$80.4K – 234
2024
Q3 		$80.4K Hold
1,200
– – 0.04% 344
2024
Q2 		$136K Hold
1,200
– – 0.07% 191
2024
Q1 		$166K Hold
1,200
– – 0.08% 159
2023
Q4 		$149K Hold
1,200
– – 0.08% 166
2023
Q3 		$112K Hold
1,200
– – 0.06% 208
2023
Q2 		$154K Hold
1,200
– – 0.09% 142
2023
Q1 		$139K Hold
1,200
– – 0.08% 154
2022
Q4 		$136K Hold
1,200
– – 0.08% 155
2022
Q3 		$97K Buy
+1,200
New +$102K 0.06% 205

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alta Advisers's DXCM Position: Q4 2024 in Review

Alta Advisers sold out of DexCom (DXCM) in Q4 2024, closing a stake of 1,200 shares — an estimated $80.4K sold.

Alta Advisers first reported a position in DXCM in Q3 2022 and held it in 9 quarters. The position peaked at $166K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Alta Advisers reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Alta Advisers sold 1,200 DexCom shares in Q4 2024, an estimated $80.4K.
  • Alta Advisers first reported a position in DexCom in Q3 2022 and held it in 9 quarters.
  • Alta Advisers's DexCom position peaked at $166K in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Alta Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.